Fulltext
The full text of this article is available on PDF
Journal of Kermanshah University of Medical Sciences
Peer-reviewed Medical Quarterly
Long-term survival in a patient with chronic myelogenous leukemia without any treatment
Author(s):
1Iran
Published online:Sep 19, 2002
Article type:Case Report
Received:Apr 11, 2002
Accepted:Sep 11, 2002
How to Cite: Shahriari A, Emaami H. Long-term survival in a patient with chronic myelogenous leukemia without any treatment. J Kermanshah Univ Med Sci. 2002;6(2):e81011. doi:
Abstract
Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy, average survival of these patients is 3-5 years. All of the long term survivors of CML have been treated patients. Here we are reporting on a long term survivor (more than 10 years) without treatment.
Copyright
© 2002, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
30
Apr
2015
Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature
Mehrdad Payandeh,
Reza Khodarahmi,
Masoud Sadeghi,
Edris Sadeghi
Payandeh M, Khodarahmi R, Sadeghi M, Sadeghi E. Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature. Int J Cancer Manag. 2015;8(2):e80601. doi:
22
Feb
2016
New Developments in Chronic Myeloid Leukemia: Implications for Therapy
Sanaz Tabarestani,
Abolfazl Movafagh
Tabarestani S, Movafagh A. New Developments in Chronic Myeloid Leukemia: Implications for Therapy. Int J Cancer Manag. 2016;9(1):e3961. doi: https://doi.org/10.17795/ijcp-3961
20
Feb
2012
Five-year survival rate of pediatric leukemia and its determinants
Sohila Zareifar,
Amir Almasi-Hashiani,
Mehran Karimi,
hamidreza tabatabaee,
Reza Ghiasvand
Zareifar S, Almasi-Hashiani A, Karimi M, tabatabaee H, Ghiasvand R. Five-year survival rate of pediatric leukemia and its determinants. koomesh. 2012;14(1):e153844. doi:
25
Nov
2012
Survival Rate of Childhood Leukemia in Shiraz, Southern Iran
Amir Almasi-Hashiani,
Soheil Zareifar,
Mehran Karimi,
Esmaeil Khedmati,
Abolfazl Mohammadbeigi
Almasi-Hashiani A, Zareifar S, Karimi M, Khedmati E, Mohammadbeigi A. Survival Rate of Childhood Leukemia in Shiraz, Southern Iran. Inn J Pediatr. 2013;23(1):. doi:
30
Apr
2015
Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran
Mehrdad Payandeh,
Masoud Sadeghi,
Edris Sadeghi
Payandeh M, Sadeghi M, Sadeghi E. Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran. Int J Cancer Manag. 2015;8(2):e80597. doi:
Download PDF276.08 KB
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 0
Last Update: 0 months ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Related Articles